Cargando…
Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?
BACKGROUND AND OBJECTIVES: The prevalence of atrial fibrillation (AF) doubles in the extreme elderly and is higher than in the rest of the population. Warfarin therapy to prevent thromboembolic events secondary to AF is often underutilized and under-prescribed in this subgroup, due to the fear of bl...
Autores principales: | Chiong, Jun R, Cheung, Rebecca J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675301/ https://www.ncbi.nlm.nih.gov/pubmed/23755073 http://dx.doi.org/10.4070/kcj.2013.43.5.287 |
Ejemplares similares
-
Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010) -
Pneumatosis cystoides intestinalis in an elderly patient, better to be safe than sorry
por: Molina, Gabriel A, et al.
Publicado: (2020) -
Better Safe Than Sorry in the Transcatheter Mitral Era
por: Denti, Paolo
Publicado: (2022) -
Inferior vena cava filters in pregnancy: Safe or sorry?
por: Bistervels, Ingrid M., et al.
Publicado: (2022) -
Serum PTH levels in dialysis: better safe than sorry
por: Cozzolino, Mario, et al.
Publicado: (2020)